Abstract-Binding characteristics of the (3-blockers and 8-agonists with the 8-adre noceptors were investigated in 3H-dihydroalprenolol (3H-DHA) binding to rat heart membranes treated with neuraminidase. When 60% of the total sialic acid content in the membranes was removed, reproducibility of the binding assay became much better than was attainable without neuraminidase treatment, and the maximum density of 19-adre noceptors was increased. These data suggest that the binding of the test compounds with the l9-adrenergic receptors in cardiac muscle was under the influence of the sialic acid of the glycocalyx of the membrane. The 3H-DHA binding sites in membranes treated with neuraminidase showed a strict stereo-specificity when tested with propranolol. The ranking order of inhibition of 8-antagonists or agonists is: dl-propranolol > oxprenolol > alprenolol > pindolol > YM-09538>labetalol> acebutolol> atenolol > metoprolol>sotalol>butoxamine>practolol as antagonists or l-isoproterenol>I epinephrine>I-norepinephrine as agonists. A good correlation (r=0.91, P<0.001) was observed between the K; values observed by the present binding assay and the pA2 observed in the guinea-pig atria relative to the positive inotropic effect by Bieth et al. (Br. J. Pharmacol. 68, 563-569, 1980), indicating that the present method will be useful for screening new (3-adrenergic receptor antagonists or agonists.
Numerous
studies have been conducted with direct radioligand binding techniques (1) (2) (3) to delineate the characteristics of cardiac autonomic receptors. In our previous report (4) , it was demonstrated that treat ment of the crude rat heart plasma membrane (sarcolemma) fraction with neuraminidase resulted in a better reproducibility than was attainable without neuraminidase treatment, with an increase in the maximum number of binding sites (Bma,) for the specific f3 adrenergic receptors. This implies that the removal of sialic acid from the glycocalyx of the sarcolemma induced an alteration of the environment of the receptor site, thus improving the reproducibility of binding of the test compounds with the receptor site. The object of this study is to examine the characteristics of the binding of (3-blockers with different potency and selectivity with the ;3-adrenoceptors in the membrane of rat heart treated with neuraminidase and to see whether the treatment with neuraminidase would bring about any change in the binding characteristics of the 8-adrenoceptors.
Materials and Methods
Male Wister rats weighing between 150 250 g were killed by a blow on the head. After removal of the heart, the ventricular muscles were minced with small scissors in 250 mM sucrose, 10 mM Tris-HCI, pH 7.6. and were then homogenized using a Polytron homogenizer, twice for 10 sec at setting 8. (0.4-0.6 mg protein) was incubated with shaking for 20 min at 23'C with 2.5 nM 3H-DHA and different concentrations of various (9-blockers in a total volume of 1 ml of 60 mM Tris-HCI, pH 8.0, and 20 mM MgC12. At the end of the incubation, the incubation medium was immediately filtered through GF/C glass filters. The filters were then washed three times with 5 ml of cold buffer. Ten ml of a Triton-toluene based scintillation fluid was added, and the radio activity of 3H-DHA bound to the membrane in the absence and presence of ,9-blockers was counted. The difference of the mean value of the total binding and the non-specific binding was taken as the specific binding. where IC50=the concentration of non radioactive drugs that inhibits 50% of the radioactive drug binding, K;=inhibition constant of a non-radioactive drug for the radioactive drug binding site, D*=free con centration of the radioactive drug (2 .5 nM) in the incubation solution , and Kd*= equilibrium dissociation constant (2.67 nM) of the radioactive drug for the binding site.
The sialic acid contents of the heart muscle treated with different concentrations of neuraminidase were measured by the method of Warren (6) . One unit (1.0 U) of neurami nidase was defined as the amount of enzyme activity which could liberate 1 nmole sialic acid/min under the assay conditions. The reaction mixture (0.1 ml) was composed of 0.1 M KCI, 10 mM MgC12, 20 mM Tris maleate, pH 7.4, containing 1.0 mM of N acetyl neuraminyl lactose and the neur aminidase (0.25 mg/ml). The homogenates were treated with the different concentrations of neuraminidase in a medium containing 100 mM KCI, 10 mM MgC12, 20 mM Tris maleate, pH 7.4, at 25'C for 30 min. Protein determination was carried out by the method of Lowry et al. (7) .
3H-Dihydroalprenolol (3H-DHA) (49 . 
Results
The amount of the membrane protein obtained with the present method from the rat heart was 62.8±10.8 mg per g wet weight without neuraminidase treatment, while it was 53.7±1.7 mg/g after treatment with neuraminidase. Figure 1 dipicts the effect of neuraminidase treatment on the binding of radioligand to (3-adrenoceptors in rat heart muscles. The density of the specific binding sites was increased after treatment of the membrane with neuraminidase as the result of a decrease in the non-specific binding sites. In addition, as decreases in the standard error show, the reproducibility of the binding became much better. Whereas the coefficient of variation of the specific binding was 83.5% without neuraminidase treatment, it was only 12.1% in neuraminidase-treated preparations. As illustrated in Fig. 2 , with the increased removal of sialic acid from the heart muscle brought about with higher concentrations of neuraminidase, the number of (3-adrenoceptor sites was increased, reaching a plateau value when 60% of the sialic acid was removed from the heart muscles.
On the basis of these findings, preliminary experiments were performed in order to standardize the Q-adrenergic receptor binding assays with the cardiac membrane pre parations treated with neuraminidase. The specific binding of 3H-DHA (2.5 nM) to the membrane fraction was linear with protein concentrations between 0.25 and 0.75 mg/ incubation medium when the antagonist (dl propranolol) was used at a saturating con centration. Total and specific bindings at 23°C were rapid, reaching steady-state within 15 min when 2.5 nM 3H-DHA was used. Binding in the presence of 5 1aM
propranolol (non-specific binding) using 2.5 nM 3H-DHA reached equilibrium in 5 min and remained constant thereafter. Figure 3 illustrates the relation between the concen tration of 3H-DHA in the incubation medium and the binding of this compound to the receptor. Scatchard analysis to determine the affinity and number of binding sites is shown in the inset. Values of the equilibrium dis sociation constant (Kd) and the maximum binding capacity (Borax) in the heart muscle treated with neuraminidase calculated from the Scatchard plot were found to be 2.67±0.5 nM and 83.5±8. 9 fmoles/mg protein, respectively. The value of the Hill coefficient equalled to unity. Table 1 summarizes the Ki values (in  hibition constants) for antagonists and agonists tested in displacement experiments using heart homogenates treated with neur The conditions for neuraminidase treatment were as described in Materials and Methods. Values are the mean+S.E. The inset shows a Scatchard plot of specific 3H-DHA binding to the membrane fraction.
Each point represents the mean of 4 experiments, each conducted in duplicate. Fig. 4 . Relationship between potencies of (3-adrenoceptor blockers relative to inhibition of 3H-DHA binding to the receptor of the neuraminidase-treated rat heart and the pA2 values as regards the inhi bition of the positive inotropic effect of isoproterenol assessed by pharmacological methods.
aminidase. The binding of propranolol showed strict stereospecificity with 1-propranolol, exhibiting two orders of magnitude higher affinities than d-propranolol. Among 10 a blockers tested, dl-propranolol, oxprenolol, alprenolol and pindolol were the most potent, while sotalol and practolol were the least potent. Labetalol and YM-09538, a combined a and 8-adrenoceptor antagonist, occupied an intermediate position as 3H-DHA binding antagonists. Relative to antagonists, agonists compounds occupied a much smaller fraction of the 3H-DHA binding sites. The rank order of the potency was I-isoproterenol>l epinephrine> I-norepinephrine. Figure 4 dipicts the relationship between the log (K;) values of 9 8-blockers and the pA2 values of the same 8-blocking agents against the positive inotropic actions of isoproterenol in the guinea-pig myocardium, which were taken from the paper of Bieth et al. (8) . A good correlation was found between K; and pA2 values, giving a straight line which can be described by the equation y=0.68x+3.22 (r=0.91, P<0.001).
Discussion
Treatment of the cardiac membrane fraction with neuraminidase resulted in a higher reproducibility of the binding assay than was obtainable without neuraminidase treatment. The coefficient of variation of the specific binding was 12.1% as compared with 83.5% for the non-treated preparation. As is well known, the sarcolemma of the cardiac muscle has a glycocalyx that consists mainly of glycosaminoglycans, so called acid muco polysaccharides, external to the unit mem branes (9) . It may be concluded that the removal of the sialic acid or some other chemical moieties from the membranes by treatment with deoxyribonuclease or neur aminidase could produce a crucial change in the environment of the Q-adrenoceptors, producing a better reproducibility with an increase in the binding sites (4, 10 values of the various i9-adrenoceptor blocking agents determined on the neur aminidase-treated membranes and the pA2 values of these compounds observed in the atria of the different species as regards the positive inotropic effects by Bieth et al. (8) . The excellent correlation provided further evidence for the identity of binding sites with the receptor. Thus, the validity of using this binding assay for the screening of new compounds reacting with ;3-adre noceptors seems to be further justified.
